END OF LIFE MEDICINES INFORMATION PACK

Similar documents
GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS

Community Pharmacists in NHS Rotherham

Berkshire Healthcare NHS Foundation Trust Becky White CHS Pharmacist April 2013

Examples of Good Practice Resource Guide

Guidelines for the Use of Subcutaneous Medications in Palliative Care

Guide to the Pharmacological Management of End of Life (Terminal) Symptoms in Residential Aged Care Residents

The Pharmacological Management of Cancer Pain in Adults. Clinical Audit Tool

How To Take A Strong Opioid Painkiller

Service Specification for NHS Community Pharmacy Palliative Care Drugs Stockist Scheme

Pain management. The WHO analgesic ladder

A Guide to pain relief medicines For patients receiving Palliative Care

Symptom Control and Caring for the Dying Patient: Palliative Care Guidelines 4th Edition

Clinical Algorithm & Preferred Medications to Treat Pain in Dialysis Patients

Clinical protocol for the use of syringe drivers in palliative care patients (adults)

OPIOIDS CONVERSION GUIDELINES 2007

Guidelines for the Use of Naloxone in Palliative Care in Adult Patients

WITHDRAWAL OF ANALGESIA AND SEDATION

Collaborative Care Plan for PAIN

Using a Graseby MS26 Syringe Driver for Continuous Subcutaneous Infusions (CSCI) Protocol

Use of opioids in Patients with Impaired Renal Function Dr Jane Neerkin, Dr Mary Brennan, Dr Humeira Jamal

Guideline for the use of subcutaneous hydration in palliative care (hypodermoclysis)

Abstral Prescriber and Pharmacist Guide

Review of Pharmacological Pain Management

LDU Maths, Stats and Numeracy Support. Metric Conversions

Guidelines for the use of Methadone for Adults with Pain in Palliative Care

Strong opioids (painkillers) in palliative care what you should know

All Wales Prescription Writing Standards

MEDICINES MANAGEMENT STANDARD OPERATING PROCEDURE (MMSOP018) Preparation of Medication Administration Record (MAR) Charts

A. ADMINISTERING SUBCUTANEOUS MEDICATIONS INTERMITTENTLY/CONTINUOUSLY B. (SUBCUTANEOUS INFUSION) HYDRODERMOCLYSIS

Guidelines for Cancer Pain Management in Substance Misusers Dr Jane Neerkin, Dr Chi-Chi Cheung and Dr Caroline Stirling

DRUG CALCULATIONS. Mathematical accuracy is a matter of life and death. [Keighley 1984]

Patient information. Using strong Opioids to control your pain

Acute management of Parkinson s

Epidural Continuous Infusion. Patient information Leaflet

Subcutaneous Medications and Palliative Care: A guide for caregivers

Standard Operating Procedure

GUIDELINES FOR THE USE OF PALIPERIDONE PALMITATE (Xeplion ) Version: 2

First published in 2006 as Guidelines for syringe driver management in palliative care. Reprinted 2007

Opioids in Palliative Care- Patient Information Manual

Anticipating And Preparing For Predictable Clinical Challenges In The Medical Care Of The Terminally Ill Person Wishing To Die At Home.

CENTRAL NERVOUS SYSTEM MANAGEMENT OF PARKINSON S DISEASE

Opioid Conversion Ratios - Guide to Practice 2013 Updated as Version 2 - November 2014

How To Treat An Alcoholic Patient

Guidelines for the Prescribing, Supply and Administration of Methadone and Buprenorphine on Transfer of Care

RGN JOY LAUDE WATFORD GENERAL HOSPITAL, ENGLAND

Opioid toxicity and alternative opioids. Palliative care fixed resource session

Pain Management in Palliative and Hospice Care

DISTRIBUTION: All Clinical Units JHCH, J1, J2, H1, Oncology Day Stay Unit & J2 Day Stay Unit. JHH Intensive Care Unit and Emergency Department

SAFE PAIN MEDICATION PRESCRIBING GUIDELINES

Lanarkshire Palliative Care. Guidelines

Nurses Self Paced Learning Module on Pain Management

PREPARATIONS: Adrenaline 1mg in 1ml (1:1000) Adrenaline 100micrograms in 1ml (1:10,000)

The TIRF REMS Access program is a Food and Drug Administration (FDA) required risk management program

Narcotic drugs used for pain treatment Version 4.3

ABC of palliative care: Principles of palliative care and pain control

Oxford University Hospitals. NHS Trust. Oxford Centre for Head and Neck Oncology. Pain Relief. Information for patients

Opioid Conversion Ratios - Guide to Practice 2013

When calculating how much of a drug is required, working with the formula helps the accuracy of the calculation.

Emergency Room Treatment of Psychosis

Yorkshire Cancer Network. North East Yorkshire and Humber Clinical Alliance

MUSC Opioid Analgesic Comparison Chart

Pharmaceutical care of people requiring palliative care Course activities

Palliative Care The Relief You Need When You re Experiencing the Symptoms of Serious Illness

Your A-Z of coping with nausea and vomiting A guide for patients and their carers. We care, we discover, we teach

Opioid Analgesics. Week 19

DRUG CALCULATIONS FOR REGISTERED NURSES ADULT SERVICES

Policy for the issue of permits to prescribe Schedule 8 poisons

Section II When you are finished with this section, you will be able to: Define medication (p 2) Describe how medications work (p 3)

Pain Control Aims. General principles of pain control. Basic pharmacokinetics. Case history demo. Opioids renal failure John Welsh 8/4/2010

Humulin R (U500) insulin: Prescribing Guidance

How To Get A Tirf

Questions and answers on breast cancer Guideline 10: The management of persistent pain after breast cancer treatment

Clinical Practice Guidelines: Nurse Practitioner, Palliative Care Service

Getting the best result from Opioid medicine. in the management of chronic pain

Crisis Management in Hospice Patients

POST-TEST Pain Resource Professional Training Program University of Wisconsin Hospital & Clinics

West of Scotland Chronic Non Malignant Pain Opioid Prescribing Guideline

OPIOID CONVERSIONS. 2. Add a rescue doses (IR) of same opioid if possible should be~10 20% of total daily opioid dose

!!! BOLUS DOSE IV. Use 5-10 mcg IV boluses STD ADRENALINE INFUSION. Use IM adrenaline in advance of IV dosing!

Your A-Z of Pain Relief A guide to pain relief medicines. We care, we discover, we teach

General PROVIDER INITIALS: PHYSICIAN ORDERS

Benzodiazepine & Z drugs withdrawal protocol

GUIDELINE FOR ADMINISTRATION OF FENTANYL FOR PAIN RELIEF IN LABOUR

MANAGEMENT OF CHRONIC NON MALIGNANT PAIN

Lumbar Fusion. Reference Guide for PACU CLINICAL PATHWAY. All patient variances to the pathway are to be circled and addressed in the progress notes.

DRUG TREATMENT OF ACUTE BEHAVIOURAL DISTURBANCE

DRUG DOSE CALCULATIONS

Pain Medication Taper Regimen Time frame to taper off days

Controlling Pain Part 2: Types of Pain Medicines for Your Prostate Cancer

Section 2 Solving dosage problems

SELECTED OPIATES TOXICITY A MODERN DAY EPIDEMIC

Southlake Psychiatry. Suboxone Contract

Naloxone Hydrochloride Injection PRODUCT INFORMATION

Pain relief at home. Information for adult patients

Transcription:

END OF LIFE MEDICINES INFORMATION PACK Advice on end of life medication is available from the nursing and medical team at St Nicholas Hospice Care - telephone 01284 766133. Many drugs used in palliative care (especially drug combinations in syringe driver) are used outside of the product licence or datasheet recommendations. However, there is wide experience of their use in palliative care. The responsibility for prescribing is taken by the prescriber (usually a doctor). Practitioners should be aware when using drugs in a manner which falls outside the product licence specification, and should be able to support their practice e.g. with references. October 2012

ANTICIPATING END OF LIFE When a patient is Deteriorating day by day Taking only sips of water No longer able to take tablets consistently Mostly bedbound May be drowsy Time is getting short Prognosis days if deteriorating day by day Explain need to focus on comfort measures, ensure analgesia Confirm preferred place of care / death Consider Is ongoing care in current location practical? what else needs to be arranged Who else needs to know / who do they want to see / be around Explain process of dying to relatives increasing drowsiness, withdrawal, body not able to utilise food, reduced ability to swallow Page 1

END OF LIFE MEDICINES To ensure common symptoms in the terminal phase eg pain, secretions and agitation are anticipated and can be managed using anticipatory drugs Consider: which medicines can be stopped which need to be continued or replaced (established analgesics, anti-emetics, anticonvulsants) for ongoing symptom control possibly by continuous subcutaneous infusion (CSCI) in a syringe driver many tablets can be prescribed as oral liquids what drugs need to be made available as PRN (as needed) medicines: prescribe and give all injections by subcutaneous route (SC) 5 common medications used in end of life care: ANALGESIC: provides background and breakthrough (as needed) analgesia ANTI EMETIC: continue existing anti-emetic if effective ANTISECRETORY: provide as needed and start CSCI as soon as any rattle starts RELAXANT / SEDATIVE: for agitation ANTICONVULSANT: Midazolam 20-30mg/24hours by CSCI is usually sufficient to manage seizures which have required anticonvulsants Page 2

ANALGESICS PRN (as needed) doses equivalent to 1/6 of 24 hour dose given as needed 2-4 hourly The correct dose is that which relieves pain for 4hrs this may be less or more than 4 hourly equivalent. If pain persists increase by 1/3 to 1/2 or guided by PRN doses used. The dose of opioid in a CSCI by syringe driver should be determined by the previous effective dose of medication used by the patient for pain control (regular and breakthrough doses): Guideline 24 hour doses by CSCI (Syringe Driver) On no opioids (eg Paracetamol only) use 5mg - 10mg Morphine or Diamorphine On full dose Codeine (240mg/day) On Morphine On Oxycodone use 20mg - 30mg Morphine or Diamorphine use equivalent dose Morphine 1/2 oral morphine dose) or Diamorphine (1/3 oral Morphine dose) use equivalent dose Oxycodone or Diamorphine (1/2 oral Oxycodone dose) SC Diamorphine and Oxycodone are equivalent mg for mg PATCHES If on Fentanyl patch leave patch in place, replace when due. Page 3

If additional pain relief required continue with patch at usual dose and use Diamorphine in syringe driver with dose based either: a) On patient use of breakthrough medication OR b) Calculated as equivalent to 1/3 to 1/2 of Fentanyl patch 24 hour equivalent thus increasing total opioid dose by 30-50% Divide the patch dose by 5 to calculate the 4 hourly SC Diamorphine dose eg 75mcg per hour patch divided by 5 = 15mg SC 4 hourly Diamorphine breakthrough dose. Multiply by 6 for 24 hour dose. See conversion chart. For other opioids use conversion chart or call for advice If indication is renal failure consider using Alfentanil ANTIEMETICS On antiemetic: If patient starting an opioid: Continue current effective antiemetic in similar dose use 2.5mg Haloperidol /24 hours unless contraindicated or 5mg - 10mg Levomepromazine / 24hrs Avoid problems: Consider the potential need to add Hyoscine to syringe driver mix for secretions as Cyclizine and Hyoscine Butylbromide (Buscopan) tend to crystallise thus making the infusion ineffective. If the patient is established on Cyclizine either change to Levomepromazine (5mg-25mg) for nausea or use Glycopyrronium rather than Hyoscine for secretions Page 4

ANTISECRETORY give early PRN as needed and continue by adding in to syringe driver Starting an antisecretory in the CSCI as soon as secretions start to be audible can prevent them becoming established. In the last days or hours respiratory secretions often build up and may cause distress to the patient and/or relatives. The key to management is not to let them become established as once they have built up they are difficult to clear. PRN dose: Hyoscine Butylbromide Glycopyrronium 20mg subcutaneously 2-4 hourly 200mcg - 400mcg 2-4 hourly CSCI: Use Hyoscine Butylbromide 60mg - 120mg over 24 hours Or Glycopyrronium 120mcg - 2400mcg over 24 hours (1.2mg - 2.4mg over 24 hours) Hyoscine Hydrobromide can be used but is more likely to cause agitation as more crosses the blood-brain barrier. Page 5

RELAXATION / SEDATION Many patients become agitated in their last hours or days and this is often the reason why out of hours services are called. Lorazepam 0.5mg - 1mg sublingually, can be given by relatives/carers 2-4 hourly PRN as needed. Midazolam subcutaneously PRN/stat works quickly in 10-15 minutes and lasts about 2 hours. If agitation is likely to recur; consider adding Midazolam to CSCI. PRN doses: Midazolam is 2.5mg - 5mg 1-2 hourly. Larger doses e.g. 5mg - 10mg Midazolam may be needed if patient already on more than 20mg/24hours in syringe driver. CSCI Starting Doses: Midazolam 10mg - 20mg is usually enough for mild to moderate agitation in a patient not previously on sedatives. Or Levomepromazine 25mg - 75mg. Severely distressed patients, heavy drinkers or those previously on anti psychotics may require higher doses or both agents together (call for advice). If patient already on Benzodiazepine - consider using Midazolam in CSCI If patient already on antipsychotic consider using Levomepromazine in CSCI End of Life Medicines in Parkinson s Disease Drugs to avoid: Haloperidol, Metaclopramide, Levomepromazine, Prochloperazine, Risperidone and Olanzapine all reduce dopamine Do not stop Levodopa suddenly (neuroleptic malignant symdrome) consider dispersible medicines via nasogastric tube or conversion to Rotigitine patch (consult medicines information WSH for dose equivalents) Page 6

AMPOULES AVAILABLE Ampoule sizes: Usual doses/24 hours: Cyclizine 50mg in 1ml 150mg Haloperidol 5mg in 1ml 5mg - 10mg for nausea Levomepromazine 25mg in 1ml 5mg - 25mg for nausea Metoclopramide 10mg in 2ml 30mg - 60mg for nausea Midazolam 10mg in 2ml 10mg - 60mg for agitation Hyoscine Butylbromide 20mg in 1ml 60mg - 120mg for secretions Glycopyrronium 200mcg in 1ml 1200mcg - 2400mcg for secretions or 600mcg in 3ml Diamorphine Morphine sulphate Oxycodone 5mg, 10mg, 30mg, 60mg, 100mg, 500mg amps 10mg, 15mg, 20mg and 30mg /ml all in 1 and 2ml amps 10mg in 1ml, 20mg in 1ml and 50mg in 1ml amps Page 7

Writing a prescription for End of Life Drugs Consider how many days supply is needed enough to cover a weekend and the time needed to arrange further supplies - 3 days minimum, 5 days more comfortable Provide enough for at least 3-4 PRN (as needed) doses per day as well as for CSCI (syringe driver) Prescribe on FP10 to obtain medicines and on Syringe Driver and PRN (as needed) charts. Provide a range of doses, this will allow dose adjustment as required. Complete directions to administer medications for District / Marie Curie / trained nurses and as a guideline for out of hours doctors who may be called. Page 8

For example, a CSCI containing: Diamorphine 20mg - 30mg Haloperidol 2.5mg Water for injection Remember to prescribe anticipatory medications for example: Midazolam 10mg - 30mg Hyoscine Butylbromide 60mg - 120mg Remember appropriate PRN (as needed) doses Prescribe on FP10 1. Diamorphine 10mg (ten) ampoules times 15 (fifteen) To be given as 20mg (twenty)/24 hours by CSCI 2. Diamorphine 5mg ampoules (Five mg) times 15 (Fifteen) To be given 2.5mg - 5mg sc 2-4 hourly for pain 3. Haloperidol 5mg amp times 5 To be given as 2.5mg/24 hours by CSCI 4. *Midazolam amp 10mg/2ml (ten in two) times 20 (twenty) * NB now a CD To be given by CSCI at 10mg - 30mg per 24 hours To be given as 2.5mg - 5mg sc 2-4 hourly as needed for agitation 5. Hyoscine Butylbromide 20mg/1ml amp times 20 To be given as 60mg - 120mg/24hours by CSCI And 20mg sc 2-4 hourly as needed for secretions Or 6. Water for injection 10ml amps x 15 7. 0.9% saline 10ml amps x15 8. Ensure supply of syringes, needles and sharps box Starting / Setting Up a Syringe Driver (Graseby) Also complete directions to administer. Page 9

Starting / Setting Up a Syringe Driver (McKinley T34) If symptomatic give stat dose as syringe driver takes 2-4 hours from setting up to achieve effect. The McKinley T34 is calibrated in ml/hour A 30ml Luer lock syringe is recommended The maximum volume of fluid in a 30ml syringe is 22ml If a 20ml Luer lock system is used, the maximum volume of fluid in a 20ml syringe is 17ml Lock on volume to be infused over 24 hours To stop syringe driver unlock cassing (key in syringe driver medication box), press Stop key Diluent 0.9% saline (not with Cyclizine) or water for injections (WFI) Site reactions are often less with saline, especially with Levomepromazine If site reactions are a problem separate the drugs into two syringe drivers, or dilute even further, or add 1 mg of Dexamethasone. Consider using a plastic rather than metal cannula. Mixtures to avoid: Cyclizine and saline it will crystallise and stop the infusion Cyclizine and Metoclopramide (antagonistic and incompatible) Cyclizine and Hyoscine (crystallises - often in the night) Metoclopramide and Hyoscine (antagonistic and incompatible) Avoid more than 1mg Dexamethasone combined with other medicines. Page 10

Compatible mixtures: Morphine/Diamorphine/Oxycodone are compatible with Haloperidol/Levomepromazine/Midazolam/Hyoscine/Glycopyrronium Dexamethasone doses greater than 1mg should be given alone. For more complex combinations consult database or call for advice. Advice on end of life medication is available from the nursing and medical team at St Nicholas Hospice Care - telephone 01284 766133. For further information contact: WSH Pharmacy 01284 713109 www.stnicholashospice.org.uk Palliative Adult Network Guidelines www.book.pallcare.info Page 11

SYRINGE DRIVER DOSE GUIDANCE FOR OPIOID NAIVE PATIENT For use in community and care homes Please allow dose adjustment to maximise symptom control One, or all of these may be needed and should be available for optimum End of Life care. SYRINGE DRIVER : For administration by continuous subcutaneous infusion Drug Dose Duration Diluent DIAMORPHINE 5mg - 10mg 24 hours Water for injection If required for relief of pain / dyspnoea HALOPERIDOL 2.5mg - 5mg 24 hours Water for injection If required for relief of nausea/vomiting BUSCOPAN 60mg - 120mg 24 hours Water for injection If required for relief of respiratory tract secretions, or as an anti-spasmodic MIDAZOLAM 10mg - 20mg 24 hours Water for injection If required for relief of agitation / terminal restlessness Page 12

PRN (AS NEEDED) DOSE medication by subcutaneous injection Drug Dose Frequency Max dose/24h DIAMORPHINE 2.5mg - 5mg 2-4hourly PRN If required for relief of pain / dyspnoea HALOPERIDOL 1mg - 2mg 2-4hourly PRN If required for relief of nausea/vomiting BUSCOPAN 20mg 2-4hourly PRN If required for relief of respiratory tract secretions, or as an anti-spasmodic MIDAZOLAM 2.5mg - 5mg 2 hourly PRN If required for relief of agitation / terminal restlessness LORAZEPAM 1mg tablet 0.5mg - 1mg Sublingual / oral 2-4 hourly PRN 2mg - 3 mg max/24hours for breathlessness or anxiety/agitation whilst waiting for professional support Page 13

SYRINGE DRIVER DOSE GUIDANCE FOR PATIENT ALREADY ON OPIOID For use in community and care homes Please allow dose adjustment to maximise symptom control One, or all of these may be needed and should be available for optimum End of Life care. SYRINGE DRIVER: For administration by continuous subcutaneous infusion Drug Dose Range Duration Diluent NaCl / Water 24 hours If required for relief of pain / dyspnoea If required for relief of nausea/vomiting 24 hours 24 hours If required for relief of respiratory tract secretions, or as an anti-spasmodic 24 hours If required for relief of agitation / terminal restlessness Page 14

PRN (AS NEEDED) dose medication by subcutaneous injection Drug Dose Frequency Max dose/24h If required for relief of pain / dyspnoea If required for relief of nausea/vomiting If required for relief of respiratory tract secretions, or as an anti-spasmodic If required for relief of agitation / terminal restlessness LORAZEPAM 1mg tablet 0.5mg - 1mg Sublingual / oral 2-4 hourly PRN 2mg - 3 mg max/24hours for breathlessness or anxiety/agitation whilst waiting for professional support Page 15

A Guide to Equivalent Doses for Opioid Drugs N.B - this is to be used as a guide rather than a set of definitive equivalences. Most data on doses is based on single dose studies so is not necessarily applicable in chronic use, also individual patients may metabolise different drugs at varying rates. The advice is always to calculate doses using Morphine as standard and to adjust then to suit the patient and the situation. Some of these doses have by necessity been rounded up or down to fit in with the preparations available. 4-hr dose (mg) Oral Morphine 12-hr SR dose (mg) 24-hr total dose (mg) Subcutaneous Morphine 4-hr dose (mg) 24-hr total dose (mg) Subcutaneous Diamorphine (oral morphine/3) 4-hr dose (mg) 24-hr total dose (mg) 4-hr dose (mg) Oral Oxycodone 12-hr SR dose (mg) 24-hr total dose (mg) Subcutaneous Oxycodone (½ - ⅔ oral dose) 4-hr dose (mg) 24-hr total dose (mg) Fentanyl Transdermal Patch Strength (mcg) 5 15 30 2.5 15 1.5 10 2.5 5 or 10 15 1.0-2.0 7.5 12 35 Transtec Patch Strength (mcg/hr) 10 30 60 5 30 3 20 5 15 30 2.5-3.5 15 12 35 3.75-15 45 90 7.5 45 5 30 7.5 25 50 5.0 25 25 52.5 20 60 120 10 60 7.5 40 10 30 60 5.0-7.0 30 37 70 30 90 180 15 90 10 60 15 45 90 7.5-10 45 50 105 40 120 240 20 120 12.5 80 20 60 120 10-12.5 60 62 140 50 150 300 25 150 15 100 25 75 150 12.5-15 75 75-60 180 360 30 180 20 120 30 90 180 15-20 90 100-70 210 420 35 210 25 140 35 105 210 17.5-20 100 112-80 240 480 40 240 27.5 160 40 120 240 20-30 120 125-90 270 540 45 270 30 180 45 135 270 Max Dose 135 150-100 300 600 50 300 35 200 50 150 300 Sub Cut 150 150 - Page 16

INJECTIONS Purpose END OF LIFE DRUGS as agreed by Suffolk PCT Dose range for bolus subcutaneous injection Maximum dose in 24 hours Syringe driver s/c 24 hours CSCI Comments Cyclizine Antiemetic 50mg every 6-8 hrs 150mg 100 or 150mg Use water for injection Diamorphine (Schedule 2 CD) Glycopyrronium Analgesic Anti-secretory agent Starting dose 2.5mg to 5mg every 2 hours See fact sheets or BNF for conversion from other opioid analgesics 200micrograms to 400micrograms every 6 hours No maximum Initially 10mg up to 30mg but varies depending on conversions from oral medications and opiate tolerance In patients needing rapid escalation of doses or doses above 200mg consult a specialist. A diluent (water for injection or sodium chloride 0.9% injection) must be prescribed for diamorphine 2400mcg 1200 up to 2400 micrograms Up to 2.4mg can be given by continuous subcutaneous infusion Haloperidol Antiemetic 0.5mg up to 2.5 once or twice a day Anxiety/agitation 1mg up to 5mg repeat every 30 minutes if required 10mg 20mg 2.5 up to 5mg 2.5 up to 10mg Hyoscine Butylbromide Anti-spasmodic / intestinal colic Bronchial secretions 20mg every 4 hours 120mg 60 up to 120mg Higher with specialist advice 20mg every 4 hours 120mg 60 up to 120mg PTO Page 17

Levomepromazine Antiemetic 5mg or 6.25mg once or twice a day Terminal agitation 25mg every 4 hours Start with 12.5mg in elderly patients 12.5mg 37.5 max for anti-emesis 12.5mg Long half life, can be given as a single dose at night if sedation a problem 150mg 25 up to 75mg Higher with specialist advice Midazolam (Schedule 3 CD Jan 08) Lorazepam Anxiety 2.5mg to 5mg every 2 hours Terminal agitation/ confusion Anticonvulsant Breathlessness or anxiety/agitation 2.5mg to 5mg every 2 hours Some need higher doses - get specialist advice 5mg repeated if required 0.5mg to 1mg sublingually 60mg 10 up to 20mg Over 40mg get specialist advice 60mg 10mg gradually titrating up Bolus dose short acting consider infusion by SD Over 40mg /24h get specialist advice 60mg 20 or 30mg The buccal route may be used for patients who are fitting ampoule contents can be used NB Lorazepam if patient not palliative 2-3mg ORAL/SUBLINGUAL for the patient to take whilst waiting for professional support Page 18

St Nicholas Hospice Care Hardwick Lane, Bury St Edmunds, Suffolk IP33 2QY Tel: Switchboard 01284 766133 Community Team 01284 702525 Fax: Referrals Office 01284 732000 Community Team 01284 715590 www.stnicholashospice.org.uk